Minretumomab

**Semantic type:** Amino Acid, Peptide, or Protein|Immunologic Factor|Pharmacologic Substance

**Definition:** A second-generation murine monoclonal antibody based on the antibody B72.3 that is directed against tumor-associated glycoprotein 72 (TAG72). TAG72 is expressed by gastric, breast, pancreatic, colorectal, and ovarian carcinoma cells. (NCI04)

**Synonyms:** - Antibody CC49, Monoclonal - CC-49 - CC-49 Monoclonal Antibody - MAb CC49 - MINRETUMOMAB - MOAB CC-49/TAG72 (DW) - MoAb CC49 - Monoclonal Antibody CC-49 - Monoclonal Antibody CC49